Association of serum apoA-I with in-stent restenosis in coronary heart disease

BACKGROUND: Despite use of drug-eluting stents (DES), in-stent restenosis (ISR) continues adversely affecting clinical outcomes of patients undergoing percutaneous coronary intervention (PCI). Apolipoprotein A-I (apoA-I) has athero-protective effects. However, there is a paucity of clinical data reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Zhang, Min, Cheng, Jie, Zhou, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354313/
https://www.ncbi.nlm.nih.gov/pubmed/35927634
http://dx.doi.org/10.1186/s12872-022-02762-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354313/
https://www.ncbi.nlm.nih.gov/pubmed/35927634
http://dx.doi.org/10.1186/s12872-022-02762-y

Ejemplares similares